Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.76 USD | +32.94% | +30.81% | -34.48% |
Business Summary
Number of employees: 68
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Genetic Diagnostic Testing
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +69.00% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Germany
100.0
%
| 1 | 100.0 % | 1 | 100.0 % | +69.00% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Guido Baechler
CEO | Chief Executive Officer | 59 | 21-06-30 |
William Caragol
DFI | Director of Finance/CFO | 58 | 21-06-30 |
Corinna Gorges
CTO | Chief Tech/Sci/R&D Officer | - | 21-10-31 |
Chief Tech/Sci/R&D Officer | - | 22-08-02 | |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Stefan Erlach
HRO | Human Resources Officer | - | - |
Amy Levin
LAW | General Counsel | - | 22-11-28 |
Jane Edwards
PRN | Corporate Officer/Principal | - | 22-06-13 |
Steve Quinn
PRN | Corporate Officer/Principal | - | 22-01-26 |
Philipp Freese
PRN | Corporate Officer/Principal | 42 | 15-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Tibbitts
BRD | Director/Board Member | 57 | 22-12-13 |
Heiner Dreismann
CHM | Chairman | 69 | 22-12-13 |
Director/Board Member | 66 | 21-10-31 | |
Guido Baechler
CEO | Chief Executive Officer | 59 | 21-06-30 |
Moritz Eidens
CTO | Chief Tech/Sci/R&D Officer | 41 | - |
Nicole Holden
BRD | Director/Board Member | 51 | 21-10-31 |
Alberto Libanori
BRD | Director/Board Member | 35 | 21-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 21,886,575 | 17,151,888 ( 78.37 %) | 0 | 78.37 % |
Company contact information
Mainz Biomed NV
Sirius Gutenberg Park Robert Koch Strasse 50
55129, Mainz
+49 6131 554 2860
http://mainzbiomed.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.48% | 16.63M | |
-24.88% | 7.74B | |
+70.87% | 4.39B | |
+2.72% | 2.61B | |
-7.18% | 2.53B | |
-44.62% | 2.22B | |
-12.67% | 1.8B | |
-19.62% | 1.54B | |
+18.85% | 1.23B | |
-43.60% | 1.15B |
- Stock Market
- Equities
- MYNZ Stock
- Company Mainz Biomed N.V.